Different molecular markers have been employed for typing Trypanosoma cruzi strains from
endemic areas of Chagas disease. The low-stringency single specific primer–polymerase …

The genetic variability of 24 Trypanosoma cruzi isolates from humans (11) and triatomines
(13) in northeastern Brazil was analyzed by random amplified polymorphic DNA (RAPD) …

Eighteen Trypanosoma cruzi strains isolated from naturally infected triatomines were studied
genetically. The majority of the strains were from Triatoma brasiliensis, the principal vector of …

Trypanosoma cruzi genetic diversity was investigated in 25 isolates (vectors and humans)
from the semiarid zone of the State of Rio Grande do Norte, Brazil. Molecular markers (3 …

Traditional molecular and biochemical methods, such as schizodeme analysis, karyotyping,
DNA fingerprinting, and enzyme electrophoretic profiles, have shown a large variability …

The clinical course of Chagas' disease varies widely among different patients and
geographic regions. For reasons that are not completely understood but involve host and …

This study aimed to identify the Trypanosoma cruzi genotypes and their relationship with
parasitic load in distinct geographic and ecotypic populations of Triatoma brasiliensis in two …

The aim of this study was to characterise Discrete Typing Units (DTUs) of 28 isolates of
Trypanosoma cruzi from humans (15), triatomines (9), and opossums (4) in the state of …

Trypanosoma cruzi, the etiologic agent of Chagas disease, presents considerable
heterogeneity between isolated populations within the wild and domestic cycles. By using …

Chagas disease is an enzootic disease, in which the flagellate Trypanosoma cruzi infects a
large variety of animals. Humans are accidentally infected due to the migration into wild …